Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
As Near-Infrared (NIR) and Raman spectroscopy become more prevalent throughout sectors, better analytical methods are needed. These tools' market dynamics reflect demand. These spectroscopic approaches aid chemical analysis, material characterization, and quality control. These strategies are all very useful.
Raman and NIR spectroscopy are being used more in agriculture, materials research, food and beverage industries, and medicine. Because of their versatility, these techniques are used in many industry and research operations. These approaches provide quick, damage-free inspections.
Technological advances in spectroscopic equipment are driving market growth. Detecting technologies, software capabilities, and equipment size reduction have improved sensitivity, resolution, and simplicity of use.
NIR and Raman spectroscopy are crucial for pharmaceutical quality monitoring, especially when developing new medications. These procedures ensure quality and regulatory compliance. Their real-time and complicated mix analysis skills explain this.
National Infrared Spectroscopy (NIR) is utilized in the food and beverage industries to quickly assess nutritional content, moisture levels, and component composition. However, Raman spectroscopy may determine food safety and pollutants.
Near-infrared spectroscopy helps farmers examine soil, monitor crops, and measure nutrients. Technology helps farmers enhance output and sustainability by improving efficiency. These methods are great for safeguarding the environment and resources since they are non-intrusive.
In chemical analysis and materials research, NIR and Raman spectroscopy have several uses. These methods let researchers conduct qualitative and quantitative material investigations. This lets them enhance polymers, nanotechnology, and semiconductor applications, among others.
Despite the improving trend, challenges must be overcome. The high initial cost of the equipment and the necessity for operating and data processing experts are two obstacles. Research institutes and smaller enterprises must overcome these challenges to expand their market share. This is particularly true for research institutes.
The worldwide Raman and near-infrared spectroscopy market is growing rapidly. North America and Europe have the highest market share due to the large number of research and pharmaceutical businesses in those nations. The Asia-Pacific region will expand rapidly due to industry and research. However, rising economies in this area are expected to rise rapidly.
The competitive landscape depends on strategic alliances and collaborations between significant competitors. Companies are cooperating to improve their product portfolios, grow their markets, and use technology and experience. This tendency will likely continue.
Analytical techniques must be reliable in the food and pharmaceutical industries due to high regulatory criteria. Compliance concerns are a major reason NIR and Raman spectroscopy is becoming more popular. This is because these procedures produce reliable, accurate analytical data.
New technologies and increased awareness of NIR and Raman spectroscopy's benefits across all industries are promising for the market. This is because spectroscopic methods are advantageous. These spectroscopic technologies will change scientific research and industrial applications due to the growing requirement for effective and accurate analytical solutions.
Glioblastoma Market Highlights:
Global Glioblastoma Market Overview
Glioblastoma Market is expected to register a CAGR of 7.60% to reach USD 2416.33 million by 2030. Glioblastoma is a type of brain tumor.The increasing occurrences of glioblastoma, a type of brain tumor, coupled with extensive research in glioblastoma treatment, and the rising adoption of chemotherapy are expected to fuel the growth of the glioblastoma market. However, the high cost of drugs and the failure of drug candidates in clinical trial phases are anticipated to hamper the market growth.
Glioblastoma Market Trends
The increasing incidence rate of glioblastoma is expected to fuel the growth of the glioblastoma market. According to the statistics published in 2017 by the National Centre for Biotechnology Information (NCBI), glioblastoma has an incidence rate of 3.19 per 100,000 persons in the US. The growing prevalence indirectly increases the healthcare expenditure of the people as well as the government. This motivates the players operating in the market to come up with alternatives for the treatment of glioblastoma. Thus, this is likely to fuel the growth of the global glioblastoma market during the forecast period.
Glioblastoma Global Market Share, by End User, 2018 (%) Â 
Source: MRFR Analysis
Glioblastoma Market Segment Insights
The global glioblastoma market has been segmented by type, treatment, and end user. The market, based on type, has been bifurcated into primary glioblastoma and secondary glioblastoma. Based on treatment, the glioblastoma market has been segregated into surgical procedure, radiation therapy, chemotherapy, and others. The global glioblastoma market, based on end user, has been divided into hospitals, specialty clinics and centers, and others. The specialty clinics and centers held a share of 36.8% in 2018.
Western Europe Glioblastoma Market Share, (%)
Source: MRFR Analysis
Glioblastoma Regional Insights
The glioblastoma global market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is likely to dominate the global glioblastoma industry. The growth in this region can be attributed to the increased cases of glioblastoma and brain tumors. Moreover, the approval of drugs helps in maximizing the growth of the market in this region.
Europe held a substantial share in the global glioblastoma market. This can be attributed to a large number of clinical trials in the region. For instance, Merck KGaA along with Vaximm GmbH is involved in Phase I and II trials to evaluate the efficacy and safety of VXM01 in combination with Avelumab in patients with resectable and non-resectable progressive glioblastoma following tumor resection and radio-chemotherapy containing temozolomide.
Asia-Pacific is estimated to be the fastest-growing region in the global market. The rise in the improved healthcare infrastructure promises a high level of research on the treatment of glioblastoma in the region.
The glioblastoma market in the Middle East & Africa is expected to witness a modest market growth rate from 2019 to 2025. The Middle East would lead the market growth in this region. Rising awareness regarding health and availability of new treatment methods are expected to drive the market growth during the assessment period.
Key Players
The prominent players in the global glioblastoma market are F. Hoffmann-La Roche Ltd (Switzerland), Arbor Pharmaceuticals, LLC (US), Merck & Co., Inc. (US), Sun Pharmaceutical Industries Ltd (India), Amgen Inc. (US), and Teva Pharmaceutical Industries Ltd (Israel).
Some of the key strategies followed by players operating in the global glioblastoma market were innovation, product development, and acquisition & mergers.
- In May 2019 Merck entered into a definitive agreement to acquire Peloton Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company, focused on the development of novel small molecule therapeutic candidates targeting hypoxia-inducible factor-2α (HIF-2α) for the treatment of patients with cancer and other non-oncology diseases.
- In January 2018Â Amgen and Allergan PLC received the approval by the European Commission (EC) for the marketing authorization of MVASI for the treatment of glioblastoma as well as certain types of cancers.
- In November 2016Â Sun Pharma acquired Biosintez, a Russian pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical products.
Glioblastoma Market Segmentation
Glioblastoma Type Outlook
- Primary Glioblastoma
- Secondary Glioblastoma
Glioblastoma Treatment Outlook
- Surgical Procedure
- Radiation Therapy
- Chemotherapy
- Others
Glioblastoma End User Outlook
- Hospitals
- Specialty Clinics and Centers
- Others
Glioblastoma Region Outlook
-
Americas-
North America- US
- Canada
- Latin America
-
-
Europe-
Western Europe- Germany
- UK
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
-
-
Asia-Pacific- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
-
Middle East & Africa- Middle East
- Africa
Available Additional Customizations
- Mega Trends in the Market
- Glioblastoma Market: Challenges
Intended Audience
- Pharmaceutical companies
- Contract research manufacturing organizations
- Research & development organizations
- Academic institutes
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
